226 related articles for article (PubMed ID: 23715497)
1. APOBEC3 deletion polymorphism is associated with breast cancer risk among women of European ancestry.
Xuan D; Li G; Cai Q; Deming-Halverson S; Shrubsole MJ; Shu XO; Kelley MC; Zheng W; Long J
Carcinogenesis; 2013 Oct; 34(10):2240-3. PubMed ID: 23715497
[TBL] [Abstract][Full Text] [Related]
2. APOBEC3 deletion polymorphism is associated with epithelial ovarian cancer risk among Chinese women.
Qi G; Xiong H; Zhou C
Tumour Biol; 2014 Jun; 35(6):5723-6. PubMed ID: 24577894
[TBL] [Abstract][Full Text] [Related]
3. A common deletion in the APOBEC3 genes and breast cancer risk.
Long J; Delahanty RJ; Li G; Gao YT; Lu W; Cai Q; Xiang YB; Li C; Ji BT; Zheng Y; Ali S; Shu XO; Zheng W
J Natl Cancer Inst; 2013 Apr; 105(8):573-9. PubMed ID: 23411593
[TBL] [Abstract][Full Text] [Related]
4. APOBEC3 deletion increases the risk of breast cancer: a meta-analysis.
Han Y; Qi Q; He Q; Sun M; Wang S; Zhou G; Sun Y
Oncotarget; 2016 Nov; 7(46):74979-74986. PubMed ID: 27602762
[TBL] [Abstract][Full Text] [Related]
5. Analysis of functional germline variants in APOBEC3 and driver genes on breast cancer risk in Moroccan study population.
Marouf C; Göhler S; Filho MI; Hajji O; Hemminki K; Nadifi S; Försti A
BMC Cancer; 2016 Feb; 16():165. PubMed ID: 26920143
[TBL] [Abstract][Full Text] [Related]
6. Germline APOBEC3B deletion is associated with breast cancer risk in an Asian multi-ethnic cohort and with immune cell presentation.
Wen WX; Soo JS; Kwan PY; Hong E; Khang TF; Mariapun S; Lee CS; Hasan SN; Rajadurai P; Yip CH; Mohd Taib NA; Teo SH
Breast Cancer Res; 2016 May; 18(1):56. PubMed ID: 27233495
[TBL] [Abstract][Full Text] [Related]
7. The 29.5 kb APOBEC3B Deletion Polymorphism Is Not Associated with Clinical Outcome of Breast Cancer.
Liu J; Sieuwerts AM; Look MP; van der Vlugt-Daane M; Meijer-van Gelder ME; Foekens JA; Hollestelle A; Martens JW
PLoS One; 2016; 11(8):e0161731. PubMed ID: 27552096
[TBL] [Abstract][Full Text] [Related]
8. APOBEC3A/B deletion polymorphism and cancer risk.
Gansmo LB; Romundstad P; Hveem K; Vatten L; Nik-Zainal S; Lønning PE; Knappskog S
Carcinogenesis; 2018 Feb; 39(2):118-124. PubMed ID: 29140415
[TBL] [Abstract][Full Text] [Related]
9. Impact of functional germline variants and a deletion polymorphism in APOBEC3A and APOBEC3B on breast cancer risk and survival in a Swedish study population.
Göhler S; Da Silva Filho MI; Johansson R; Enquist-Olsson K; Henriksson R; Hemminki K; Lenner P; Försti A
J Cancer Res Clin Oncol; 2016 Jan; 142(1):273-6. PubMed ID: 26320772
[TBL] [Abstract][Full Text] [Related]
10. Association of APOBEC3 deletion with cancer risk: A meta-analysis of 26 225 cases and 37 201 controls.
Hashemi M; Moazeni-Roodi A; Taheri M
Asia Pac J Clin Oncol; 2019 Dec; 15(6):275-287. PubMed ID: 30693645
[TBL] [Abstract][Full Text] [Related]
11. Replication and functional genomic analyses of the breast cancer susceptibility locus at 6q25.1 generalize its importance in women of chinese, Japanese, and European ancestry.
Cai Q; Wen W; Qu S; Li G; Egan KM; Chen K; Deming SL; Shen H; Shen CY; Gammon MD; Blot WJ; Matsuo K; Haiman CA; Khoo US; Iwasaki M; Santella RM; Zhang L; Fair AM; Hu Z; Wu PE; Signorello LB; Titus-Ernstoff L; Tajima K; Henderson BE; Chan KY; Kasuga Y; Newcomb PA; Zheng H; Cui Y; Wang F; Shieh YL; Iwata H; Le Marchand L; Chan SY; Shrubsole MJ; Trentham-Dietz A; Tsugane S; Garcia-Closas M; Long J; Li C; Shi J; Huang B; Xiang YB; Gao YT; Lu W; Shu XO; Zheng W
Cancer Res; 2011 Feb; 71(4):1344-55. PubMed ID: 21303983
[TBL] [Abstract][Full Text] [Related]
12. Clinical Implications of APOBEC3-Mediated Mutagenesis in Breast Cancer.
Roelofs PA; Martens JWM; Harris RS; Span PN
Clin Cancer Res; 2023 May; 29(9):1658-1669. PubMed ID: 36478188
[TBL] [Abstract][Full Text] [Related]
13. DNA replication stress mediates APOBEC3 family mutagenesis in breast cancer.
Kanu N; Cerone MA; Goh G; Zalmas LP; Bartkova J; Dietzen M; McGranahan N; Rogers R; Law EK; Gromova I; Kschischo M; Walton MI; Rossanese OW; Bartek J; Harris RS; Venkatesan S; Swanton C
Genome Biol; 2016 Sep; 17(1):185. PubMed ID: 27634334
[TBL] [Abstract][Full Text] [Related]
14. Analysis of APOBEC3A/3B germline deletion polymorphism in breast, cervical and oral cancers from South India and its impact on miRNA regulation.
Revathidevi S; Manikandan M; Rao AK; Vinothkumar V; Arunkumar G; Rajkumar KS; Ramani R; Rajaraman R; Ajay C; Munirajan AK
Tumour Biol; 2016 Sep; 37(9):11983-11990. PubMed ID: 27155849
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of an APOBEC3 deletion polymorphism for glioma patients in Taiwan.
Chen CH; Wei KC; Liao WC; Lin YY; Chen HC; Feng LY; Liu CH; Huang CY; Chen KT; Wu CS; Chang YS; Yu JS; Chang IY
J Neurosurg; 2023 May; 138(5):1325-1337. PubMed ID: 36152319
[TBL] [Abstract][Full Text] [Related]
16. Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry.
Zhao Z; Wen W; Michailidou K; Bolla MK; Wang Q; Zhang B; Long J; Shu XO; Schmidt MK; Milne RL; García-Closas M; Chang-Claude J; Lindstrom S; Bojesen SE; Ahsan H; Aittomäki K; Andrulis IL; Anton-Culver H; Arndt V; Beckmann MW; Beeghly-Fadiel A; Benitez J; Blomqvist C; Bogdanova NV; Børresen-Dale AL; Brand J; Brauch H; Brenner H; Burwinkel B; Cai Q; Casey G; Chenevix-Trench G; Couch FJ; Cox A; Cross SS; Czene K; Dörk T; Dumont M; Fasching PA; Figueroa J; Flesch-Janys D; Fletcher O; Flyger H; Fostira F; Gammon M; Giles GG; Guénel P; Haiman CA; Hamann U; Harrington P; Hartman M; Hooning MJ; Hopper JL; Jakubowska A; Jasmine F; John EM; Johnson N; Kabisch M; Khan S; Kibriya M; Knight JA; Kosma VM; Kriege M; Kristensen V; Le Marchand L; Lee E; Li J; Lindblom A; Lophatananon A; Luben R; Lubinski J; Malone KE; Mannermaa A; Manoukian S; Margolin S; Marme F; McLean C; Meijers-Heijboer H; Meindl A; Miao H; Muir K; Neuhausen SL; Nevanlinna H; Neven P; Olson JE; Perkins B; Peterlongo P; Phillips KA; Pylkäs K; Rudolph A; Santella R; Sawyer EJ; Schmutzler RK; Schoemaker M; Shah M; Shrubsole M; Southey MC; Swerdlow AJ; Toland AE; Tomlinson I; Torres D; Truong T; Ursin G; Van Der Luijt RB; Verhoef S; Wang-Gohrke S; Whittemore AS; Winqvist R; Pilar Zamora M; Zhao H; Dunning AM; Simard J; Hall P; Kraft P; Pharoah P; Hunter D; Easton DF; Zheng W
Cancer Causes Control; 2016 May; 27(5):679-93. PubMed ID: 27053251
[TBL] [Abstract][Full Text] [Related]
17. European ancestry is positively associated with breast cancer risk in Mexican women.
Fejerman L; Romieu I; John EM; Lazcano-Ponce E; Huntsman S; Beckman KB; Pérez-Stable EJ; González Burchard E; Ziv E; Torres-Mejía G
Cancer Epidemiol Biomarkers Prev; 2010 Apr; 19(4):1074-82. PubMed ID: 20332279
[TBL] [Abstract][Full Text] [Related]
18. Association of a germline copy number polymorphism of APOBEC3A and APOBEC3B with burden of putative APOBEC-dependent mutations in breast cancer.
Nik-Zainal S; Wedge DC; Alexandrov LB; Petljak M; Butler AP; Bolli N; Davies HR; Knappskog S; Martin S; Papaemmanuil E; Ramakrishna M; Shlien A; Simonic I; Xue Y; Tyler-Smith C; Campbell PJ; Stratton MR
Nat Genet; 2014 May; 46(5):487-91. PubMed ID: 24728294
[TBL] [Abstract][Full Text] [Related]
19. Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042.
Milne RL; Benítez J; Nevanlinna H; Heikkinen T; Aittomäki K; Blomqvist C; Arias JI; Zamora MP; Burwinkel B; Bartram CR; Meindl A; Schmutzler RK; Cox A; Brock I; Elliott G; Reed MW; Southey MC; Smith L; Spurdle AB; Hopper JL; Couch FJ; Olson JE; Wang X; Fredericksen Z; Schürmann P; Bremer M; Hillemanns P; Dörk T; Devilee P; van Asperen CJ; Tollenaar RA; Seynaeve C; Hall P; Czene K; Liu J; Li Y; Ahmed S; Dunning AM; Maranian M; Pharoah PD; Chenevix-Trench G; Beesley J; ; ; Bogdanova NV; Antonenkova NN; Zalutsky IV; Anton-Culver H; Ziogas A; Brauch H; Justenhoven C; Ko YD; Haas S; Fasching PA; Strick R; Ekici AB; Beckmann MW; Giles GG; Severi G; Baglietto L; English DR; Fletcher O; Johnson N; dos Santos Silva I; Peto J; Turnbull C; Hines S; Renwick A; Rahman N; Nordestgaard BG; Bojesen SE; Flyger H; Kang D; Yoo KY; Noh DY; Mannermaa A; Kataja V; Kosma VM; García-Closas M; Chanock S; Lissowska J; Brinton LA; Chang-Claude J; Wang-Gohrke S; Shen CY; Wang HC; Yu JC; Chen ST; Bermisheva M; Nikolaeva T; Khusnutdinova E; Humphreys MK; Morrison J; Platte R; Easton DF;
J Natl Cancer Inst; 2009 Jul; 101(14):1012-8. PubMed ID: 19567422
[TBL] [Abstract][Full Text] [Related]
20. Genetic ancestry modifies the association between genetic risk variants and breast cancer risk among Hispanic and non-Hispanic white women.
Fejerman L; Stern MC; Ziv E; John EM; Torres-Mejia G; Hines LM; Wolff R; Wang W; Baumgartner KB; Giuliano AR; Slattery ML
Carcinogenesis; 2013 Aug; 34(8):1787-93. PubMed ID: 23563089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
